In patients with severe CKD and suspected ACS, the diagnostic performance of hs-cTnT to differentiate an acute myocardial injury due to presumed NSTE-ACS from a preexisting chronic one is improved by using higher assay-specific cutoff levels combined with early absolute changes. This evidence concerns the gene TNNT2 and chronic kidney disease.